• 08.02.2019

    Aurealis Pharma Announces 7.8MCHF Financing to Advance the Chronic Wound Lead Candidate AUP-16 to Diabetic Foot Ulcer Patients under New Brand Aurealis Therapeutics AG

  • 15.10.2018

    Aurealis Pharma Submitted Clinical Trial Application for First-in-Human Phase 1-2A Clinical Study to German Health Authority Paul-Ehrlich-Institute (PEI)

  • 22.05.2018

    Aurealis Pharma to Strengthen It´s Board of Directors by Appointing Mr. Iain Buchanan, a Seasoned Biotech and Pharma Industry Executive

  • 30.04.2018

    Aurealis Pharma To Present at the European Wound Management Association (EWMA) Congress 2018 in Krakow, Poland, May 9th – 11th 2018

  • 26.04.2018

    Aurealis Pharma To Attend The Swiss Biotech Day in Basel, May 3rd 2018

  • 19.02.2018

    Aurealis Pharma To Present at the 11th Annual European Life Sciences CEO Forum & Exhibition in Zurich, February 26-27th 2018

  • 06.02.2018

    Aurealis Pharma to Present at Swiss Nordic Bio 2018 in Zurich, February 8th 2018

  • 24.09.2017

    Aurealis Pharma to Present at Sachs Associates 17th Annual Biotech in Europe Forum Basel, September 26-27th 2017

  • 20.09.2017

    Aurealis Pharma to Present at BioPharm America 10th Annual International Partnering Conference in Boston, September 26-27th 2017

  • 25.08.2017

    Aurealis Pharma Announces 5.6MCHF Series A Financing to Advance Chronic Wound and Oncology Lead Products

  • Aurealis Pharma to Discuss AUP-16 Clinical Development at the 27th European Wound Managament Association Annual Meeting on May 3-5th 2017 in Amsterdam

  • Aurealis Pharma to Present at Swiss Biotech Day on May 4th 2017

  • 11.01.2017

    Aurealis Pharma to Attend 9th Annual Partnering Conference - Biotech Showcase, San Francisco, January 9-11th 2017

  • 12.10.2016

    Aurealis Pharma to Present at Sachs Associates 16th Annual Biotech in Europe Forum Basel, September 27-28th 2016

  • 10.05.2016

    Aurealis Pharma Expands Its Board of Directors with Mr. Silvio Inderbitzin and Mr. Roger Meier

  • 08.04.2016

    Aurealis Pharma to Attend Swiss Biotech Day on April 12th 2016

  • 06.04.2016

    Aurealis Pharma to Move Swiss Offices to Technology Park Basel

  • 24.03.2016

    Aurealis Pharma to Showcase at BioTrinity 2016 - Europe's Leading Investment and Biopartnering Conference, London, April 25-27th 2016

  • 22.01.2016

    Aurealis Pharma Extends Microbiology, Genetic Engineering and Manufacturing Expertise by Recruitment of Industry Expert Dr. Igor Mierau

  • 07.01.2016

    Aurealis Pharma Completes 3.3MCHF Seed C Financing to Advance Its Multitherapy Biologics

  • 04.09.2015

    Aurealis Pharma Expands its Management Team and Announces Opening of New Office In Basel Switzerland

  • 13.05.2015

    Aurealis Pharma to Attend BioEquity Europe 2015 Conference, Vienna on May 19-20th 2015

  • 04.05.2015

    Aurealis Pharma to Present at Asia Biotech Invest 2015 Conference on May 21st 2015

  • 16.04.2015

    Aurealis Pharma to Present at BioTrinity 2015 - European Biopartnering and Investment Conference on May 12th 2015

  • 13.04.2015

    Aurealis Pharma Completes Second Round of Seed Financing to Advance Its Immune Microenvironment Modulation Technology

Back to previous page


Aurealis Pharma

Embracing science. Enhancing lives.

Site by Mainostoimisto Ad Kiivi